Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies.

This article discusses recent advances in PET quantification that can improve reliability and accuracy of characterizing hematological malignancies." PMID: 31084773 [PubMed - in process]
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Tags: PET Clin Source Type: research

Related Links:

Publication date: Available online 19 October 2019Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Domenico Albano, Rexhep Durmo, Giorgio Treglia, Raffaele Giubbini, Francesco BertagnaABSTRACTMucosa associated lymphoid tissue (MALT) lymphoma is a lymphoma involving the mucosa-associated lymphoid tissue potentially arising from any mucosal site with stomach as most common site of involvement. MALT lymphoma is usually a not aggressive disease with good prognosis except of selected cases. Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) is a non-invasive imaging tool use...
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Our aim was to compare the extent of myeloma bone disease (MBD) evaluated by radiodiagnostic methods, conventional radiography (X-ray), low-dose computed tomography (LD-CT) and magnetic resonance imaging (MRI), to selected markers of bone metabolism and bone marrow microenvironment.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research
In this study, we investigated the prognostic role of 18F-FDG PET/CT in patients with MM presenting with RI.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research
Publication date: Available online 30 August 2019Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Zuzan Cayci, Kerem Ozturk, Celalettin Ustun, Aazim K. Omer, Erhan Dincer, Zohar Sachs, Bruce A. Peterson, Michael A. LindenAbstractSarcoidosis has been shown to be associated with increased risk of development of several malignancies including lymphomas. On the other hand, “sarcoid-like reactions” in the absence of other clinical signs of sarcoidosis, have also been described in patients who had been treated with chemotherapy for a wide variety of malignancies. In this article, we report 3 cases who had PET...
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Publication date: Available online 30 August 2019Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Zuzan Cayci, Kerem Ozturk, Celalettin Ustun, Aazim K. Omer, Erhan Dincer, Zohar Sachs, Bruce A. Peterson, Michael A. LindenAbstractSarcoidosis has been shown to be associated with increased risk of development of several malignancies including lymphomas. On the other hand, “sarcoid-like reactions” in the absence of other clinical signs of sarcoidosis, have also been described in patients who had been treated with chemotherapy for a wide variety of malignancies. In this article, we report 3 cases who had PET...
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Conclusion18F-FDG PET/CT showed excellent detection rate in nodal and splenic disease—a rate better than CT. For BM and GI evaluation, in order to reach good accuracy, the selection of patients and the use of specific criteria for evaluation of these organs seems to be crucial. Moreover, PET/CT altered the management and therapeutic approach in about 20% of patients.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
This study is designed to explore the potential prognostic value of baseline FDG-PET-derived quantitative metrics in T cell lymphomas in a retrospective single-center study. Methods: Among sixty four patients with newly diagnosed T and NK cell lymphomas from July 2010 to December 2017 in Peking University First Hospital underwent positron emission tomography/computed tomography (PET/CT) scans, 47 cases who were followed up with complete clinical materials were retrospectively reviewed and analyzed. Patient's clinical characteristics included Ann Arbor stage, clinical symptoms, lactate dehydrogenase (LDH) levels, internatio...
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Lymphoma / Leukemia / Myeloma Posters Source Type: research
Conclusions: Tislelizumab or Camrelizumab could be a new treatment option for patients with relapsed or refractory classical Hodgkin lymphoma in China. Three-month 18F-FDG PET/CT scans detected HL patients responding to anti-PD1. New patterns were encountered in 15% of patients, emphasizing the need for further evaluation in larger series and close collaboration between imaging and oncology specialists on a per-patient basis.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Lymphoma / Leukemia / Myeloma Posters Source Type: research
Conclusions: SUVmax at biopsy site was positively correlated with Ki-67 and CD5, suggesting that tumour metabolic activity seems to be related to the proliferation and aggressiveness. Keywords T lymphomas, PET/CT, Maximum standardized uptake value, Immunophenotypes
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Lymphoma / Leukemia / Myeloma Posters Source Type: research
Conclusions: Focal increased FDG metabolic activity in the parotid gland require further investigation especially in the head and neck malignancy or if the results may change treatment plan as many will have unexpected metastasis.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Other Solid Tumors Posters Source Type: research
More News: Cancer & Oncology | CT Scan | Hematology | Lymphoma | Myeloma